The US GMP Cytokines Market is witnessing strong growth, supported by the country’s advanced biotechnology ecosystem, expanding cell and gene therapy pipeline, and established GMP manufacturing infrastructure. Rising adoption of CAR-T, T-cell, and NK-cell therapies is increasing demand for high-quality GMP-grade cytokines used in cell activation, expansion, and differentiation processes....